Pliant Therapeutics PLRX
NASDAQ PLRX
$1.15 +0.03 (+3.12%)
At close: Aug 21, 2026 · 4:00 PM EDT

Pliant Therapeutics (PLRX) FCF Margin Growth (3y) (2023)

Pliant Therapeutics (PLRX) FCF Margin Growth (3y) (2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -1,272.00
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -2,228.00
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -5,426.00
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 9,545.00
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 4,612.00
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 1,850.00
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 14,060.00
9 Royalty Pharma 27.27 Bn 26.43 Bn - -3,088.00
10 Pliant Therapeutics 71.52 Mn 71.52 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2023 -1.05 Mn
Mar 31, 2023 -222,966.00